-The Hindu The ongoing peaceful protest against the Kudankulam nuclear power plant (KKNPP), which began in the early 1980s intensified after the March 2011 Fukushima nuclear disaster. The protests revolve around fears over public safety and health arising from the existence and operation of the nuclear facility. The protesters, the men, women and children of Idinthakarai and surrounding villages, have consistently demanded transparency and honest public consultation. They do not need high...

-The Hindustan Times Fifty per cent of drinking water supplied to north Delhi is not fit for consumption and is a carrier of cholera, typhoid and Jaundice, surveys conducted by the North Delhi Municipal Corporation have found. On the other hand, people in south Delhi get clean, drinkable water, said a recent survey by the civic body’s south arm and the Delhi Jal Board (DJB). The north Delhi corporation said that of...

-The Sunday Indian  When I first heard about two journalists battling for life after returning from a reporting assignment in the Abujmarh jungles of Chattisgarh, from a journalist friend, I was left unmoved. In journalistic circles, while we haven't yet lost on our emotions, it's a proud feeling to see a fellow journalist excel at reportage from an inaccessible corner, especially when the reporter is still a cub in the field....

-IANS Kolhapur (Maharashtra): More than 500 new cases of Jaundice have been reported from the textile town of Ichalkaranji in Kolhapur district in the last four days and the disease has killed at least 12 people in the last one month, officials said on Monday. Kolhapur health department suspect that the consumption of contaminated water of Panchganga river by the people is the cause behind the recent rise in cases of Jaundice...

-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...